HuGE Literature Finder
Records
1
-
24
| Bevacizumab versus Ramucirumab in EGFR-Mutated Metastatic Non-Small-Cell Lung Cancer Patients: A Real-World Observational Study. Cancers 2023 2 15 (3): . Cheng Wen-Chien, Shen Yi-Cheng, Chen Chieh-Lung, Liao Wei-Chih, Chen Chia-Hung, Chen Hung-Jen, Tu Chih-Yen, Hsia Te-Ch |
| Role of plasmatic and urinary concentration of tenofovir disoproxil fumarate in a cohort of patients affected by chronic hepatitis B. Archives of virology 2022 May . Boglione Lucio, De Benedetto Ilaria, Dodaro Valentina, Chiecchio Marta, De Nicolò Amedeo, Di Perri Giovanni, D'Avolio Anton |
| Acute fulminant hepatitis associated with osimertinib administration in a lung cancer patient with chronic hepatitis B: The first mortality case report. Thoracic cancer 2022 2 13 (7): 1091-1094. Kang You-Kuang, Meng Fan-Ch |
| An open label, safety study of Asian patients with advanced non-small-cell lung cancer receiving second-line nivolumab monotherapy (CheckMate 870). Therapeutic advances in medical oncology 2022 11 14 17588359221138380. Lu Shun, Cheng Ying, Zhou Jianying, Wang Mengzhao, Zhao Jun, Wang Baocheng, Chen Gongyan, Feng Jifeng, Ma Zhiyong, Wu Lin, Wang Changli, Ma Kewei, Zhang Shucai, Liang Jun, Song Yong, Wang Jie, Wu Yi-Long, Li Ang, Huang Yizhi, Chang Jianh |
| Nonreceptor protein tyrosine phosphatases (NRPTPs) gene family associates with the risk of hepatocellular carcinoma in a Chinese hepatitis B virus-related subjects. Molecular carcinogenesis 2020 Jun . Shen Na, Wang Peng, Li Ying, Zhu Yaowu, Gong Yajie, Zhong Rong, Lu Yanjun, Cheng Limi |
| Use of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection and severe renal impairment. Clinical and molecular hepatology 2020 8 26 (4): 554-561. Yap Desmond Y H, Liu Kevin S H, Hsu Yu-Chun, Wong Grace L H, Tsai Ming-Chang, Chen Chien-Hung, Hsu Ching-Sheng, Hui Yee Tak, Li Michael K K, Liu Chen-Hua, Kan Yee-Man, Yu Ming-Lung, Yuen Man-Fu |
| Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA. Clinical cancer research : an official journal of the American Association for Cancer Research 2019 8 25 (20): 6107-6118. Kaseb Ahmed O, Sánchez Nora S, Sen Shiraj, Kelley Robin K, Tan Benjamin, Bocobo Andrea G, Lim Kian H, Abdel-Wahab Reham, Uemura Marc, Pestana Roberto Carmagnani, Qiao Wei, Xiao Lianchun, Morris Jeffrey, Amin Hesham M, Hassan Manal M, Rashid Asif, Banks Kimberly C, Lanman Richard B, Talasaz AmirAli, Mills-Shaw Kenna R, George Bhawana, Haque Abedul, Raghav Kanwal P S, Wolff Robert A, Yao James C, Meric-Bernstam Funda, Ikeda Sadakatsu, Kurzrock Razel |
| Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study. Journal of gastroenterology and hepatology 2018 8 34 (2): 364-369. Atsukawa Masanori, Tsubota Akihito, Toyoda Hidenori, Takaguchi Koichi, Kondo Chisa, Okubo Tomomi, Hiraoka Atsushi, Michitaka Kojiro, Fujioka Shinichi, Uojima Haruki, Watanabe Tsunamasa, Ikeda Hiroki, Asano Toru, Ishikawa Toru, Matsumoto Yoshihiro, Abe Hiroshi, Kato Keizo, Tsuji Kunihiko, Ogawa Chikara, Shimada Noritomo, Iio Etsuko, Mikami Shigeru, Tanaka Yasuhito, Kumada Takashi, Iwakiri Katsuhi |
| Immunotherapy in the Asiatic population: any differences from Caucasian population? Journal of thoracic disease 2018 6 10 (Suppl 13): S1482-S1493. Peng Lunxi, Wu Yi-Lo |
| EGFR rs11506105 and IFNL3 SNPs but not rs8099917 are strongly associated with treatment responses in Iranian patients with chronic hepatitis C. Genes and immunity 2017 09 18 (3): 144-151. Asnavandi M, Zargar M, Vaziri F, Jamnani F R, Gharibzadeh S, Fateh A, Siadat S |
| Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting. Clinical and experimental pharmacology & physiology 2016 Nov . Milazzo Laura, Gervasoni Cristina, Falvella Felicia Stefania, Cattaneo Dario, Mazzali Cristina, Ronzi Paola, Binda Francesca, Cheli Stefania, Sollima Salvatore, Antinori Spinel |
| Sofosbuvir plus daclatasvir with or without ribavirin for chronic hepatitis C infection: Impact of drug concentration on viral load decay. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2016 Jul . Virlogeux Victor, Choupeaux Laure, Pradat Pierre, Maynard Marianne, Bailly François, Scholtès Caroline, Gagnieu Marie-Claude, Zoulim Fabi |
| Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy. AIDS (London, England) 2016 May . Kheloufi Farid, Bellissant Eric, Cotte Laurent, Poizot-Martin Isabelle, Quaranta Sylvie, Garraffo Rodolphe, Barrail-Tran Aurélie, Renault Alain, Fournier Isabelle, Lacarelle Bruno, Bourlière Marc, Molina Jean-Michel, Solas Caroline, |
| EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma. Scientific reports 2016 08 6 31237. Han Chuangye, Liao Xiwen, Qin Wei, Yu Long, Liu Xiaoguang, Chen Gang, Liu Zhengtao, Lu Sicong, Chen Zhiwei, Su Hao, Zhu Guangzhi, Lu Zili, Liu Zhiming, Qin Xue, Gui Ying, Mo Zengnan, Li Lequn, Peng T |
| Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas. Journal of gastroenterology and hepatology 2015 Sep 30 (9): 1397-404. Su Yu-Hung, Ng Kwai-Fong, Yu Ming-Chin, Wu Ting-Jung, Yeh Ta-Sen, Lee Wei-Chen, Lin Yong-Shiang, Hsieh Tsung-Han, Lin Chun-Yen, Yeh Chau-Ting, Chen Tse-Chi |
| Polymorphisms in EGFR and IL28B are associated with spontaneous clearance in an HCV-infected Iranian population. Genes and immunity 2015 Sep . Carapito R, Poustchi H, Kwemou M, Untrau M, Sharifi A H, Merat S, Haj-Sheykholeslami A, Jabbari H, Esmaili S, Michel S, Toussaint J, Le Gentil M, Ansari-Moghaddam A, Radosavljevic M, Etemadi A, Georgel P, Malekzadeh R, Bahram |
| Influence of ABCC2 and ABCC4 polymorphisms on tenofovir plasma concentrations in Thai HIV-infected patients. Antimicrobial agents and chemotherapy 2015 Jun 59 (6): 3240-5. Rungtivasuwan Kanokrat, Avihingsanon Anchalee, Thammajaruk Narukjaporn, Mitruk Siwaporn, Burger David M, Ruxrungtham Kiat, Punyawudho Baralee, Pengsuparp Thiti |
| Telaprevir and ribavirin interaction: higher ribavirin levels are not only due to renal dysfunction during triple therapy. Antimicrobial agents and chemotherapy 2015 Jun 59 (6): 3257-62. Gutierrez-Valencia Alicia, Ruiz-Valderas Rosa, Ben-Marzouk-Hidalgo Omar J, Torres-Cornejo Almudena, Espinosa Nuria, Castillo-Ferrando Juan R, Viciana Pompeyo, Lopez-Cortes Luis |
| Telaprevir decreases estimated glomerular filtration rate in HIV-hepatitis C virus coinfected patients. AIDS (London, England) 2015 May 29 (8): 977-9. Van den Eynde Eva, Curto Jordi, Ferrer Elena, Imaz Arkaitz, Saumoy Maria, Di Yacovo Silvana, Vila Antonia, Podzamczer Dani |
| Influence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects. PloS one 2015 10 (7): e0132640. Oniki Kentaro, Saruwatari Junji, Izuka Tomoko, Kajiwara Ayami, Morita Kazunori, Sakata Misaki, Otake Koji, Ogata Yasuhiro, Nakagawa Kazu |
| Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis C virus infection. Cancer science 2014 Jun 105 (6): 646-50. Yoshiya Shohei, Fujimoto Yukiko, Bekki Yuki, Konishi Hideyuki, Yamashita Yo-Ichi, Ikegami Toru, Yoshizumi Tomoharu, Shirabe Ken, Oda Yoshinao, Maehara Yoshihi |
| Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China. Genetic testing and molecular biomarkers 2013 Aug 17 (8): 595-600. Wu Jia, Zhang Wei, Xu Aiqiang, Zhang Li, Yan Tao, Li Zhuo, Wu Xiaopan, Zhu Xilin, Ma Juan, Li Ke, Li Hui, Liu Yi |
| Genetic variations in humans associated with differences in the course of hepatitis C. Biochemical and biophysical research communications 2004 Apr 317 (2): 335-41. Saito T, Ji G, Shinzawa H, Okumoto K, Hattori E, Adachi T, Takeda T, Sugahara K, Ito JI, Watanabe H, Saito K, Togashi H, Ishii K, Matsuura T, Inageda K, Muramatsu M, Kawata S |
| Microalbuminuria and pegylated interferon in hepatitis-C patients. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 0 26 (6): 1183-9. Elshahawi Yasser, Sany Dawlat, Abd Elmohsen Walid Anwar, Tantawi Tar |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 31, 2023
- Content source: